期刊文献+

肝硬化患者生存质量及相关因素的研究进展 被引量:21

Factors affecting quality of life in patients with cirrhosis
暂未订购
导出
摘要 肝硬化是消化内科临床上常见的一种慢性疾病,起病隐匿,病程迁延难愈,晚期出现的各种并发症更是严重地影响着患者的生活质量,使患者不但经历生理、心理、生活和经济的痛苦,在环境和精神上也备受困扰,对人们健康危害极为严重.故近年来肝病专家强烈呼吁重视肝硬化患者生存质量的评价.而影响肝硬化患者生存质量因素很多,如性别、年龄、文化程度、经济、病程、病情程度、Child分级、晚期各种并发症等.但其中以病程、病情程度、肝功能分级及晚期并发症的出现影响最大,本文综述了近5年来影响肝硬化患者生存质量的主要因素,以期更好地了解肝硬化患者的生存质量. Cirrhosis is a very common chronic disease with an insidious onset and a protracted course.Many kinds of complications may occur in patients with advanced liver cirrhosis.Patients with cirrhosis have seriously affected quality of life and have to suffer great physical and mental pain.Evaluation of quality of life in patients with cirrhosis is of great significance for the management of this disease.The quality of life in patients with cirrhosis is influenced by many factors,including sex,age,education,economy,duration,severity,Child classification,and late complications.Of these factors,disease course,severity,liver function grade and late complications have the greatest impact.In this paper we review major factors that affect quality of life in patients with cirrhosis.
出处 《世界华人消化杂志》 CAS 北大核心 2013年第20期1945-1949,共5页 World Chinese Journal of Digestology
关键词 肝硬化 生存质量 主要因素 Cirrhosis Quality of life Major factors
  • 相关文献

参考文献35

  • 1Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 1993; 2: 153-159 PubMed DOI.
  • 2Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transpl Surg 1999; 5: 318-331 PubMed DOI.
  • 3Bayliss MS. Methods in outcomes research in hepatology: definitions and domains of quality of life. Hepatology 1999; 29: 3S-6S PubMed.
  • 4Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45: 295-300 PubMed DOI.
  • 5Bajaj JS, Thacker LR, Wade JB, Sanyal AJ, Heuman DM, Sterling RK, Gibson DP, Stravitz RT, Puri P, Fuchs M, Luketic V, Noble N, White M, Bell D, Revicki DA. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther 2011; 34: 1123-1132 PubMed DOI.
  • 6Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-115 PubMed DOI.
  • 7Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J 2005; 24: 755-760 PubMed DOI.
  • 8Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891 PubMed DOI.
  • 9Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538 PubMed DOI.
  • 10Romero-Figueroa S, Ceballos-Salgado E, Santillán-Arreygue L, Miranda-García M, Rubio-Lezama M, Gardu?o-García JJ. Risk factors associated with hepatitis C virus infection in an urban population of the State of Mexico. Arch Virol 2012; 157: 329-332 PubMed DOI.

二级参考文献94

共引文献146

同被引文献180

引证文献21

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部